Standardized flow cytometry for highly sensitive MRD measurements in B-cell acute lymphoblastic leukemia.
about
Validation of an automated technique for ovarian cortex dissociation: isolation of viable ovarian cells and their qualification by multicolor flow cytometryHigh-throughput sequencing for noninvasive disease detection in hematologic malignancies.A QA program for MRD testing demonstrates that systematic education can reduce discordance among experienced interpreters.Is Next-Generation Sequencing the way to go for Residual Disease Monitoring in Acute Lymphoblastic Leukemia?Flow cytometry-Recognizing unusual populations in leukemia and lymphoma diagnosis.Next-generation sequencing indicates false-positive MRD results and better predicts prognosis after SCT in patients with childhood ALL.Minimal residual disease-guided therapy in childhood acute lymphoblastic leukemia.Redefining treatment failure for pediatric acute leukemia in the era of minimal residual disease testing.Current applications of multiparameter flow cytometry in plasma cell disorders.Ficoll-hypaque separation vs whole blood lysis: Comparison of efficiency and impact on minimal residual disease analysis.Automated database-guided expert-supervised orientation for immunophenotypic diagnosis and classification of acute leukemia.An update on PCR use for minimal residual disease monitoring in acute lymphoblastic leukemia.Efficacy and safety of native versus pegylated Escherichia coli asparaginase for treatment of adults with high-risk, Philadelphia chromosome-negative acute lymphoblastic leukemia.Measurable residual disease detection by high-throughput sequencing improves risk stratification for pediatric B-ALL.Surface expression of Cytokine Receptor-Like Factor 2 increases risk of relapse in pediatric acute lymphoblastic leukemia patients harboring IKZF1 deletions.
P2860
Q33827472-13C85BB2-0089-41E6-B505-48A5FEEAA102Q38672646-76C8C051-B3FD-4E7C-9919-D3BD06A707B4Q38802404-A1088F0B-0FA0-4B2D-925E-761F08D56241Q38815331-A1A6E979-A1A2-48D0-84F9-0BBB78DD9528Q38817660-81779E4C-1BF6-4452-B886-1B1224E016D0Q38937419-A0485EAF-CD63-4D5A-B5B9-7FB9E91678D6Q39123286-D9EB1546-6A95-4961-8B4D-3F6A0053ABF2Q46103668-75B78E02-25AD-4600-AF10-1911A9F4E120Q47110039-D977183F-A687-4505-BBA7-67601B512CFEQ47367539-4ECA21EE-0C79-46F6-AC7C-96304B78EED9Q47393763-B24DEE07-7AC4-4F16-BA49-65127AF9109FQ47955491-1F977BBE-7C10-4153-A258-F0AB59E9B289Q49818206-42A4AEBA-A20A-4B06-AEC1-A464445D560CQ52735368-05BD58C9-9ED1-462E-A67E-ECE5A5388FAAQ55346725-59AC1890-A7F3-4725-8662-CA3C95AD9844
P2860
Standardized flow cytometry for highly sensitive MRD measurements in B-cell acute lymphoblastic leukemia.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Standardized flow cytometry fo ...... acute lymphoblastic leukemia.
@en
Standardized flow cytometry fo ...... acute lymphoblastic leukemia.
@nl
type
label
Standardized flow cytometry fo ...... acute lymphoblastic leukemia.
@en
Standardized flow cytometry fo ...... acute lymphoblastic leukemia.
@nl
prefLabel
Standardized flow cytometry fo ...... acute lymphoblastic leukemia.
@en
Standardized flow cytometry fo ...... acute lymphoblastic leukemia.
@nl
P2093
P2860
P50
P1433
P1476
Standardized flow cytometry fo ...... acute lymphoblastic leukemia.
@en
P2093
Alberto Orfao
Alita J van der Sluijs-Gelling
Chiara Buracchi
Edwin Sonneveld
Elaine Sobral da Costa
Elen Oliveira
Ester Mejstrikova
EuroFlow Consortium
Eva Froňková
Georgiana Emilia Grigore
P2860
P304
P356
10.1182/BLOOD-2016-07-726307
P407
P577
2016-11-30T00:00:00Z